Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Kristin G. I. Mohn"'
Autor:
Amit Bansal, Mai-Chi Trieu, Kristin G. I. Mohn, Anders Madsen, Jan Stefan Olofsson, Helene Heitmann Sandnes, Marianne Sævik, Hanne Søyland, Lena Hansen, Therese Bredholt Onyango, Camilla Tøndel, Karl Albert Brokstad, Bergen COVID-19 research group, Heidi Syre, Åse Garløv Riis, Nina Langeland, Rebecca Jane Cox, Håkon Amdam, Geir Bredholt, Nina Urke Ertesvåg, Elisabeth Berg Fjellveit, Sarah Lartey, Fredrik Grøvan, Hauke Bartsch, Kanika Kuwelker, Juha Vahokoski, Bård Kittang, Linchausen Dagrun Waag, Bjørn Blomberg, Fan Zhou
Publikováno v:
Frontiers in Public Health, Vol 11 (2023)
BackgroundPreventing infection in healthcare workers (HCWs) is crucial for protecting healthcare systems during the COVID-19 pandemic. Here, we investigated the seroepidemiology of SARS-CoV-2 in HCWs in Norway with low-transmission settings.MethodsFr
Externí odkaz:
https://doaj.org/article/197878fbe8e94d96880f7287027e4d99
Autor:
Nina Urke Ertesvåg, Julie Xiao, Fan Zhou, Sonja Ljostveit, Helene Sandnes, Sarah Lartey, Marianne Sævik, Lena Hansen, Anders Madsen, Kristin G. I. Mohn, Elisabeth Fjelltveit, Jan Stefan Olofsson, Tiong Kit Tan, Pramila Rijal, Lisa Schimanski, Siri Øyen, Karl Albert Brokstad, Susanna Dunachie, Anni Jämsén, William S. James, Adam C. Harding, Heli Harvala, Dung Nguyen, David Roberts, PHE Virology group, Maria Zambon, Oxford collaborative group, Alain Townsend, Bergen COVID-19 Research Group, Nina Langeland, Rebecca Jane Cox
Publikováno v:
Communications Medicine, Vol 2, Iss 1, Pp 1-11 (2022)
Ertesvåg, Xiao et al. describe a method to evaluate neutralising antibodies to SARS-CoV-2 infection or vaccination, including variants of concern. A second mRNA-vaccine dose results in a broader antibody repertoire in adults, although with reduced c
Externí odkaz:
https://doaj.org/article/cbafc65b10794cc39ff63dc23d9135f0
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Annual influenza vaccination is often recommended for pregnant women and young children to reduce the risk of severe influenza. However, most studies investigating the safety, immunogenicity, and efficacy or effectiveness of influenza vaccines are co
Externí odkaz:
https://doaj.org/article/1d8f2e67aecb42fcab98707a89bfc10c
Autor:
Nina Urke Ertesvåg, Arild Iversen, Bjørn Blomberg, Türküler Özgümüş, Pramila Rijal, Elisabeth Berg Fjelltveit, Rebecca Jane Cox, Nina Langeland, Kjell Haug, Helene Sandnes, Kristin G-I Mohn, Jan Stefan Olofsson, Marianne Sævik, Christopher James Brokstad, Kanika Kuwelker, Kristin Heienberg
Publikováno v:
eBioMedicine. 92:104599
Autor:
Elisabeth B, Fjelltveit, Bjørn, Blomberg, Kanika, Kuwelker, Fan, Zhou, Therese B, Onyango, Karl A, Brokstad, Rebecca, Elyanow, Ian M, Kaplan, Camilla, Tøndel, Kristin G I, Mohn, Türküler, Özgümüş, Rebecca J, Cox, Nina, Langeland
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
The burden and duration of persistent symptoms after non-severe COVID-19 remains uncertain. This study aimed to assess post-infection symptom trajectories in home-isolated COVID-19 cases compared to age- and time-period matched seronegative controls,
Autor:
Nina Urke Ertesvåg, Sunniva Todnem Sakkestad, Fan Zhou, Ingrid Hoff, Trygve Kristiansen, Trygve Müller Jonassen, Elisabeth Follesø, Karl Albert Brokstad, Ruben Dyrhovden, Kristin G.-I. Mohn
Publikováno v:
Viruses
Background: Persistent fever after SARS-CoV-2 infection in rituximab-treated patients has been reported. Due to reduced sensitivity in conventional sampling methods and unspecific symptoms in these patients, distinguishing between low-grade viral rep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f5656d31e94290c973e6adcb2c36476
https://hdl.handle.net/11250/3059870
https://hdl.handle.net/11250/3059870
Autor:
Nina Urke Ertesvåg, Rebecca Jane Cox, Sarah Larteley Lartey, Kristin G-I Mohn, Karl Albert Brokstad, Mai-Chi Trieu
Publikováno v:
npj Vaccines
History of influenza A/H3N2 exposure, especially childhood infection, shape antibody responses after influenza vaccination and infection, but have not been extensively studied. We investigated the breadth and durability of influenza A/H3N2-specific h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86e9e7f1950de52cbbce091d6f2bc0a6
https://hdl.handle.net/11250/3040244
https://hdl.handle.net/11250/3040244
Autor:
Kristin G.-I. Mohn, Rebecca Jane Cox, Eirik Alnes Buanes, Elisabeth B. Fjelltveit, Bård Reiakvam Kittang, Nina Langeland, Bjørn Blomberg
Publikováno v:
Infectious Diseases
Background COVID-19 patients are extensively treated with antibiotics despite few bacterial complications. We aimed to study antibiotic use in hospitalized COVID-19 patients compared to influenza patients in two consecutive years. Furthermore, we inv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85d36e02178b55b24df6bbf2df89cdeb
https://hdl.handle.net/11250/2991566
https://hdl.handle.net/11250/2991566
Autor:
Adam Harding, Sonja Ljostveit, Lena Hansen, Helene Heitmann Sandnes, Jan Olofsson, Heli Harvala, Kristin G.-I. Mohn, Tiong Kit Tan, Sarah Lartey Jalloh, Pramila Rijal, David L. Roberts, Karl Broksatd, Rebecca Jane Cox, Lisa Schimanski, Elisabeth B. Fjelltveit, Julie Xiao, Sir Øyen, Marianne Sævik, Fan Zhou, Nina Urke Ertesvåg, Nina Langeland, Susanna Dunachie, Anni Jämsén, Alain Townsend, Anders Madsen, William James, Maria Zambon
Evaluation of susceptibility to emerging SARS-CoV-2 variants of concern (VOC) requires rapid screening tests for neutralising antibodies which provide protection. We developed a receptor-binding domain specific hemagglutination test (HAT) which corre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd2ae88bbe5b045ead4384f618dc71ed
https://doi.org/10.21203/rs.3.rs-879130/v1
https://doi.org/10.21203/rs.3.rs-879130/v1
Autor:
Kristin G-I, Mohn, Geir, Bredholt, Fan, Zhou, Anders, Madsen, Therese B, Onyango, Elisabeth B, Fjelltveit, Sarah L, Jalloh, Karl A, Brokstad, Diego, Cantoni, Martin, Mayora-Neto, Nigel, Temperton, Nina, Langeland, Rebecca J, Cox
Publikováno v:
e0261979
PLOS ONE
PLoS ONE
PLOS ONE
PLoS ONE
Background Neutralizing antibodies are important for protection against the pandemic SARS-CoV-2 virus, and long-term memory responses determine the risk of re-infection or boosting after vaccination. T-cellular responses are considered important for